Pharmacists in Massapequa Park, New York


12 Pharmacists found in Massapequa Park
male pharmacist

Joseph Evan Deegidio, RPH, PHARMD


Pharmacist
5125 Merrick Rd, Massapequa Park, NY 11762
516-798-7676    

male pharmacist

Mr. Kenneth W Schwarz, RPH


Pharmacist
153 Atlantic Ave, Massapequa Park, NY 11762
516-455-9038    

female pharmacist

Lorrell Herman, RPH


Pharmacist
66 Eastlake Ave, Massapequa Park, NY 11762
516-798-4395    



female pharmacist

Maria Plumeri, RPH


Pharmacist
1022 Park Boulevard, Massapequa Park, NY 11762
515-798-9444     516-798-0589

female pharmacist

Marisa Anne Simmons, PHARM D.


Pharmacist
403 1st Ave, Massapequa Park, NY 11762
516-663-2101    

male pharmacist

Mr. Michael Rothstein, R.PH.


Pharmacist
440 Pacific St, Massapequa Park, NY 11762
917-696-1823    

female pharmacist

Mrs. Patricia A Cummings, RPH


Pharmacist
1022 Park Blvd, Massapequa Park, NY 11762
516-798-9444     516-798-0589

female pharmacist

Rose Dioguardi


Pharmacist
5125 Merrick Rd, Massapequa Park, NY 11762
516-798-7676     516-795-4059

female pharmacist

Roseanne Svec, RPH


Pharmacist
1022 Park Blvd, Massapequa Park, NY 11762
516-798-9444     516-798-0589

male pharmacist

Mr. Todd A Svec, RPH


Pharmacist
1022 Park Blvd, Massapequa Park, NY 11762
516-798-9444     516-798-0589

male pharmacist

Dr. Willber Alexander Velasquez, RPH


Pharmacist
5125 Merrick Rd, Massapequa Park, NY 11762
516-798-7676    

male pharmacist

William Schwetz


Pharmacist
5125 Merrick Rd, Massapequa Park, NY 11762
516-798-7676     516-795-4059


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.